molybdenum has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishino, H; Kawahito, Y; Kimura, M; Kohno, M; Omoto, A; Prudovsky, I; Sano, H; Tubouchi, Y; Wada, M; Yoshida, M; Yoshikawa, T; Yoshimura, R | 1 |
| Abrams, GD; Brewer, GJ; Dick, R; Hou, G; McCubbin, MD; Zhang, Z | 1 |
2 other study(ies) available for molybdenum and Adjuvant Arthritis
| Article | Year |
|---|---|
Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Biomarkers; Cachexia; Chelating Agents; Chelation Therapy; Copper; Disease Models, Animal; Female; Hindlimb; Immunoenzyme Techniques; Joints; Molybdenum; Rats; Rats, Inbred Lew; Synovial Membrane; Vascular Endothelial Growth Factor A | 2005 |
Tetrathiomolybdate is effective in a mouse model of arthritis.
Topics: Administration, Oral; Animals; Antirheumatic Agents; Arthritis, Experimental; Ceruloplasmin; Chelating Agents; Copper; Cytokines; Edema; Erythema; Isoprostanes; Joints; Male; Mice; Mice, Inbred DBA; Molybdenum; Treatment Outcome; Water Supply | 2006 |